EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Prophylactic anticoagulation in children receiving home parenteral nutrition: An international prospective multicenter study

Aysenur Demirok, Sjoerd C J Nagelkerke, Samantha C Gouw, Barbara A E de Koning, C Heleen van Ommen, Rozemarijn Duister, Marc A Benninga, Cécile Lambe, Merit M Tabbers

Clinical Nutrition · 2025

DOI: 10.1016/j.clnu.2025.01.023 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Nutrition, 2025. Verfasst von Aysenur Demirok und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Gastroenterology, Hepatology and Nutrition, Emma Children's Hospital, Amsterdam University Medical Centers University of Amsterdam, Amsterd…. Hauptthemen laut MEDLINE: Anticoagulants, Parenteral Nutrition, Home, Thrombosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Catheter-related thrombosis (CRT) is a serious complication associated with home parenteral nutrition (HPN) in children with chronic intestinal failure (CIF). Guidelines on pediatric HPN state that there is insufficient evidence to advocate the prophylactic use of CRT. Aim is to evaluate the efficacy and safety of prophylactic anticoagulation in preventing CRT in children on HPN. METHODS: We performed a prospective, international, multicenter study across three expertise centers. Children aged 0-18 years on HPN were included and divided into two groups: 1) primary/secondary prophylaxis- and 2) non-prophylaxis group. Participants were followed for 24 months and screened for CRT using ultrasonography annually. Primary outcomes included total incidence of CRT per 1000 catheter days, and association between prophylactic anticoagulation and CRT. Propensity score stratification and logistic regression were used to evaluate the association between prophylactic anticoagulation and CRT, adjusting for significant covariates differing between groups. Balance was visually assessed before and after stratification, and statistical significance (p < 0.05) was determined. Secondary outcomes included incidence of catheter-related bloodstream infections (CRBSI) and bleeding events per 1000 catheter days. RESULTS: A total of 115 children, mean age of 6,9 years (SD 4,6), were included. Fifty-seven patients were receiving prophylactic anticoagulation (50 %). The overall incidence of CRT was 0.17 per 1000 catheter days in 13 patients (11 %), with no significant difference between the prophylaxis (n = 6) and non-prophylaxis group (n = 7) (odds ratio 0.64, 95 % CI: 0.12-3.4, p = 0.60). Incidence rate of CRBSIs was 0.34/1000 catheter days (n = 25). Patients with CRT during follow up were significantly more likely to have a CRBSI (54 %) compared to those without (14 %) (p = 0.010). Two minor bleeding events were reported in the prophylaxis group, resulting in an incidence of 0,03/1000 catheter days. CONCLUSIONS: Our study shows that prophylactic anticoagulation does not significantly reduce the incidence of CRT in children on HPN. Our results do underline the clinical importance of optimal catheter care and infection prevention as CRBSIs were more likely to occur in patients with CRT, and emphasize the need for larger multicenter trials to establish evidence-based recommendations for the use of prophylactic anticoagulation in children on HPN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsParenteral Nutrition, HomeThrombosisHumansChildMaleProspective StudiesFemaleChild, PreschoolInfantAdolescentCatheter-Related InfectionsInfant, NewbornIncidenceIntestinal Failure

Stichwörter der Autor:innen

Catheter-related thrombosisLow molecular weight heparinPediatricVitamin K antagonist

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Pediatric Gastroenterology, Hepatology and Nutrition, Emma Children's Hospital, Amsterdam University Medical Centers University of Amsterdam, Amsterdam, the Netherlands. Electronic address: a.demirok@amsterdamumc.nl.
  • Pediatric Gastroenterology, Hepatology and Nutrition, Emma Children's Hospital, Amsterdam University Medical Centers University of Amsterdam, Amsterdam, the Netherlands.
  • Pediatric Hematology, Emma Children's Hospital, Amsterdam University Medical Centers University of Amsterdam, Amsterdam, the Netherlands.
  • Pediatric Gastroenterology, Hepatology and Nutrition, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Pediatric Hematology & Oncology, Erasmus MC Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Department of Pediatric Gastroenterology and Nutrition, Hôpital Necker-Enfants Malades, Université Paris Cité, Paris, France.

Zitieren

APA

Demirok, A., Nagelkerke, S. C. J., Gouw, S. C., de Koning, B. A. E., Heleen van Ommen, C., Duister, R., Benninga, M. A., Lambe, C., & Tabbers, M. M. (2025). Prophylactic anticoagulation in children receiving home parenteral nutrition: An international prospective multicenter study. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2025.01.023

Vancouver

Demirok A, Nagelkerke SCJ, Gouw SC, de Koning BAE, Heleen van Ommen C, Duister R, et al. Prophylactic anticoagulation in children receiving home parenteral nutrition: An international prospective multicenter study. Clinical Nutrition. 2025. doi:10.1016/j.clnu.2025.01.023

BibTeX
@article{Demirok2025,
  author = {Demirok, Aysenur and Nagelkerke, Sjoerd C J and Gouw, Samantha C and de Koning, Barbara A E and Heleen van Ommen, C and Duister, Rozemarijn and Benninga, Marc A and Lambe, Cécile and Tabbers, Merit M},
  title = {Prophylactic anticoagulation in children receiving home parenteral nutrition: An international prospective multicenter study},
  journal = {Clinical Nutrition},
  year = {2025},
  doi = {10.1016/j.clnu.2025.01.023}
}
Kostenlos starten →